Hypertension
Conditions
Brief summary
This study identify prescription patterns of Lodient Tab and evaluate the changes of the hypertension symptoms (BP pressure) who are first prescribed and taking Lodient Tab.
Detailed description
This study aims to observe changes in symptoms according to the treatment effect of hypertension for 6 months after Lodient Tab prescription.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
1. Adults over 19 years of age 2. A person diagnosed with hypertension 3. A person who has been first prescribed Lodient Tab within the past 4 months as of the IRB approval date or is scheduled to be prescribed Lodient Tab 4. A person who voluntarily agreed in writing to this study
Exclusion criteria
1. Pregnant women or nursing mothers 2. Persons subject to prohibition according to the permission of the Lodient Tab 3. Patients who in the judgement of the investigator, were inappropriate to participate in the study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The percentage of patients who met target systolic blood pressure (less than 140mmHg) at 6 months of prescription for Lodient Tab compared to baseline | at 6 months of prescription for Lodient Tab compared to baseline | The percentage of patients who met target systolic blood pressure (less than 140mmHg) at 6 months of prescription for Lodient Tab compared to baseline |
Countries
South Korea